Zydus Lifesciences informs about press release

25 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 25, 2025, titled ‘Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

885.55 9.45 (1.08%)
22-Jan-2026 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1643.00
Dr. Reddys Lab 1217.50
Cipla 1380.50
Zydus Lifesciences 885.55
Lupin 2185.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×